Qun Luo

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown et al. · The Lancet Respiratory Medicine · 2020 · 522 citations · Full text

Inbuild Trial, Parallel-group Trial, Advanced Lung Disease +5

Sequential changes of serum KL-6 predict the progression of interstitial lung disease

Ying Jiang, Qun Luo, Qian Han et al. · Journal of Thoracic Disease · 2018 · 77 citations · Full text

Changes of gut microbiota in diabetic nephropathy and its effect on the progression of kidney injury

Kedan Cai, Yanhong Ma, Fanghao Cai et al. · Endocrine · 2022 · 56 citations

Kidney Injury, Urology, Renal Disease +13

Forced vital capacity predicts the survival of interstitial lung disease in anti-MDA5 positive dermatomyositis: a multi-centre cohort study

Wanlong Wu, Wenwen Xu, Wenjia Sun et al. · Lara D. Veeken · 2021 · 51 citations

The change of gut microbiota‐derived short‐chain fatty acids in diabetic kidney disease

Chenyu Zhong, Zhiwei Dai, Lingxiong Chai et al. · Journal of Clinical Laboratory Analysis · 2021 · 41 citations · Full text